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Abstract
The CaBPs represent a subfamily of small EF-hand containing calcium (Ca
2+)-sensing proteins related to calmodulin that
regulate key ion channels in the mammalian nervous system. In a recent bioinformatic analyses we determined that CaBP7
and CaBP8 form an evolutionarily distinct branch within the CaBPs (also known as the calneurons) a finding that is
consistent with earlier observations characterising a putative C-terminal transmembrane (TM) spanning helix in each of
these proteins which is essential for their sub-cellular targeting to the Golgi apparatus and constitutive secretory vesicles.
The C-terminal position of the predicted TM-helix suggests that CaBP7 and CaBP8 could be processed in a manner
analogous to tail-anchored integral membrane proteins which exhibit the ability to insert across membranes post-
translationally. In this study we have investigated the topology of CaBP7 and CaBP8 within cellular membranes through a
combination of trypsin protection and epitope accessibility analyses. Our results indicate that the TM-helices of CaBP7 and
CaBP8 insert fully across membranes such that their extreme C-termini are luminal. The observed type-II membrane
topology is consistent with processing of CaBP7 and CaBP8 as true tail-anchored proteins. This targeting mechanism is
distinct from any other calmodulin related Ca
2+-sensor and conceivably underpins unique physiological functions of these
proteins.
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Introduction
The calcium ion (Ca
2+) is a signalling intermediate fundamental
to many aspects of mammalian physiology and influences
processes ranging from fertilisation to cell death, modulation of
gene transcription, ion channel function, exocytosis and phospho-
lipid metabolism [1]. Ca
2+ is able to exert such far reaching effects
due to the existence of a diverse complement of dedicated Ca
2+-
sensing proteins each of which exhibits unique Ca
2+-binding
properties coupled to specific patterns of tissue and cellular
expression [2]. Ca
2+-sensors characteristically respond to the
magnitude, timing and spatial localisation of a given Ca
2+ signal to
elicit an appropriate intracellular response and subsequent
alteration in cellular activity [3]. A key feature of Ca
2+-sensing
proteins is that they often exhibit restricted sub-cellular localisa-
tions, a quality fundamental to their ability to integrate specific
subsets of Ca
2+ signals that are in turn linked to particular cellular
pathways. The largest group of Ca
2+-sensors are those comprising
the calmodulin (CaM) super-family of small EF-hand containing
proteins and members of this family exhibit extensive diversity in
both how they bind Ca
2+ and Mg
2+ ions and specifically target to
unique sub-cellular domains [2]. The Ca
2+-binding proteins
(CaBPs) are a subfamily of the CaM related proteins [4,5,6]
which have emerged as important regulators of pivotal ion
channels and intracellular trafficking enzymes. The CaBPs consist
of seven proteins [6] most of which have been demonstrated to
regulate specific target proteins and this functional diversity is
mirrored by differences in how each CaBP is targeted to discrete
sub-cellular sites. CaBP1 has three splice variants [7], two of which
become N-myristoylated, a post-translational acylation modifica-
tion essential to membrane association with the Golgi complex
and plasma membrane [8,9]. This targeting mechanism is shared
by other Ca
2+-sensing proteins and has been elaborated on
extensively during evolution to provide a surprisingly diverse and
flexible means of associating proteins with specific membrane
domains [8,10]. In all instances thus far examined myristoylation
of the Ca
2+-sensor and hence correct sub-cellular targeting has
been proven indispensible to protein function [9,11]. Other
members of the CaBP family (Caldendrin, CaBP4 and CaBP5)
contain no obvious consensus motifs for myristoylation or other
specific targeting information and consistent with this are
predominantly cytosolic [12,13,14,15]. It is likely however that
they have the capacity to become specifically targeted in response
to Ca
2+-binding through interactions with proteins that themselves
specifically localise [16].
Within the CaBP family there exists an additional example of
evolutionary diversification with regards to sub-cellular protein
targeting in the form of CaBP7 and CaBP8 (also referred to as
calneurons II and I respectively, [5]). These proteins contain no
consensus motifs for N-myristoylation yet display distinct patterns
of membrane association when expressed in cells where they are
restricted to the trans-Golgi network (TGN) and vesicular
structures. The sub-cellular targeting of CaBP7 and CaBP8 is
attributable to the presence of a highly hydrophobic helix at the
extreme C-terminus of the protein that is predicted to be a
transmembrane (TM) domain. In a previous study [15] we
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that the predicted TM domain was essential for the correct
localisation of CaBP7 and CaBP8 to membranes and moreover
that this sequence alone was sufficient to target a normally
cytosolic protein to identical membrane domains. The C-terminal
position of the CaBP7 and CaBP8 TM helix parallels the
organisation observed for the tail-anchored (TA) class of integral
membrane proteins [17,18]. This membrane protein type is
evolutionarily conserved and includes proteins essential to
intracellular trafficking and mitochondrial architecture/function.
TA protein topology consists of a large cytosolic N-terminal
functional domain, a TM helix and short luminal C-terminus. The
key feature of TA proteins is that due to the lack of an N-terminal
signal peptide and emergence of their TM domain close to the
point of translation termination, they are not typically co-
translationally translocated across membranes in a Sec61 depen-
dent manner. Instead it has been observed that TA proteins are
dealt with quite differently to other TM proteins and can be
inserted across membranes post-translationally although the
mechanistic details of how this happens remain to be resolved at
the molecular level [19].
In a previous study we described a putative TM helix present in
CaBP7 and CaBP8 that could account for correct sub-cellular
targeting of both proteins but we did not determine that this was a
true TM domain [15]. In the present study we have now formally
established that these hydrophobic sequences are indeed TM
domains by determining the membrane topology of CaBP7 and
CaBP8 through a combination of protease protection [20] and
epitope accessibility analyses [21]. Our data indicate that both
fluorescently- and myc-tagged reporter constructs behave identi-
cally and exhibit a type-II membrane topology. These findings
demonstrate unequivocally the presence of functional TM
domains in CaBP7 and CaBP8 that are responsible for driving
the correct membrane localisation and membrane orientation of
the Ca
2+-sensors. We additionally demonstrate that these proteins
are a new TA class of Ca
2+-sensor. This targeting mechanism is
likely to be essential for the emerging function of these proteins as
regulators of vesicular trafficking events in the secretory pathway




N-terminally and C-terminally mCherry or EYFP tagged full
length CaBP7 and CaBP8 were generated as previously described
[15]. Enhanced cyan fluorescent protein vector (ECFP-C1) was
obtained from Clontech (CA, USA). CaBP7 tagged with c-myc at
the carboxy-terminal end (mCherry-CaBP7-myc) was made by
PCR sub-cloning using wild-type CaBP7 template and previously
described sense primer [15] in combination with a reverse primer
encoding the ten amino acid sequence (EQKLISEEDL) of c-myc
[23]: 59-AACCAGGTGCTGCGCAGTGGCATGAAGGAA-
CAAAAACTTATTTCTGAAGAAGATCTGTAGCCGCGG-
GCCCGGATAT-39. The resultant PCR product was digested
with HindIII and SacII and ligated into mCherry-N1 (a gift from
Dr. R. Tsien, University of California).
Cell culture and transfection
HeLa cells [24] were maintained in DMEM supplemented with
5% foetal bovine serum, 1% penicillin/streptomycin and 1% non-
essential amino acids in a humidified atmosphere of 5% CO2/
95% air at 37uC. Cells were transiently transfected using
Genejuice transfection reagent (Novagen) according to the
manufacturer’s protocol. For co-localisation studies cells plated
onto glass coverslips were transfected with 1 mg of each construct.
Biochemical protease protection assay
Equal numbers of HeLa cells were grown on 6-well plates
(Corning) and wells transfected in duplicate with 3 mg of either:
mCherry-C1, mCherry-CaBP7 or CaBP7-mCherry. Twenty-four
hours post-transfection cells from 1 well for each condition were
washed in KHM buffer (110 mM potassium acetate, 20 mM
HEPES (pH 7.2), 2 mM MgCl2) then treated with 40 mM
Digitonin in KHM buffer for 1 min at room temperature. After
permeabilisation cells were washed in KHM buffer and challenged
with 4 mM trypsin in KHM buffer for 5 min at room
temperature. Cells were washed and protein extracted by boiling
in an appropriate volume of Laemmli buffer. Control cells not
treated with digitonin or trypsin were processed identically. Equal
aliquots of the samples were subjected to SDS-PAGE and western
blot analysis using a rabbit polyclonal RFP antibody (a gift from
Dr. Ian Prior, University of Liverpool). Relative amounts of
protein in individual tracks were quanitated using the densitom-
etry function of ImageJ (NIH, USA) and averaged data from
multiple independent experiments calculated 6 Standard Error of
the Mean (SEM).
Fluorescence protease protection assay
Cells were plated onto glass bottomed dishes (MatTek
corporation) and triply transfected with 1 mg of each of the three
constructs: ECFP-C1, EYFP-CaBP7/CaBP8 and CaBP7/CaBP8-
mCherry. Fluorescence protease protection assays were performed
as previously described [25]. Briefly, twenty-four hours after
transfection cells were washed three times in KHM buffer at room
temperature. The cell chamber was set up on the microscope stage
and imaging started during this ‘pre-permeabilisation’ stage.
Frames were collected at a rate of 1frame every 8 seconds. Cells
were then perfused with KHM buffer containing 40 mM digitonin
until ECFP fluorescence started to dissipate. Perfusion was first
switched to KHM buffer until all the ECFP fluorescence had
disappeared (10–60 sec) and then to KHM containing 4 mM
trypsin. Images were recorded until EYFP signal was lost.
Antibody accessibility experiments
Cells were plated onto glass coverslips and transfected with 1 mg
of mCherry-CaBP7-myc or mCherry-CaBP8-myc. 24 hours post-
transfection cells were washed and permeabilised in the following
ways: Selective permeabilisation of the plasma membrane was
obtained by treating cells with 40 mM digitonin in KHM buffer for
one minute before fixation using 4% formaldehyde in PBS.
Control cells were fixed and permeabilised with 0.2% (v/v) Triton-
X-100 for non-selective solubilisation of all cellular membranes.
Cells from both conditions were immunostained with either a
monoclonal anti-c-myc antibody (1:100, 9E10 clone, Sigma,
Poole, UK) or a rabbit polyclonal anti-RFP antibody (1:100, a
kind gift from Dr I. Prior, University of Liverpool) followed by
FITC-conjugated goat anti-mouse or goat anti-rabbit secondary
antibodies (1:75, Sigma, Poole, UK) in PBS containing 5% BSA.
Fluorescence and microscopy and imaging
Endogenous CaBP7 localisation was detected using a rabbit
polyclonal anti-CaBP7 antibody (1:200, Santa Cruz Biotechnol-
ogy) followed by staining with FITC conjugated goat anti-rabbit
secondary antibody. Fixed and live cells were imaged using a Leica
TCS-140 SP-MP microscope (Leica Microsystems, Heidelberg,
Germany) with a 22 mm pinhole and x63 oil immersion objective.
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to eliminate bleed-through between channels. Fluorescence
intensity was quantified using Leica Lite confocal software (Leica
Microsystems) by drawing a region of interest around the Golgi
using the stack profile tool. Data was exported into Microsoft
Excel (Microsoft Office, 2007) and fluorescence intensity in each
frame (F) expressed as a percentage of the fluorescence at the start
of the experiment (F0). Graphs were generated using Excel and
OriginPro 8 (OriginLab corporation). Images were exported as
TIFF files and compiled using ImageJ and CorelDraw X4 (Corel
Corporation).
Results
Localisation of tagged CaBP7 and CaBP8 in HeLa cells
In order to characterise the membrane topology of CaBP7 and
CaBP8 we constructed N- and C-terminal fluorescently tagged
variants of both proteins and assessed their distributions in
transiently transfected HeLa cells (Figure 1). Consistent with our
previous studies examining the membrane targeting of these
proteins in Neuro2A cells [15], C-terminally tagged CaBP7 and
CaBP8 (CaBP7-mCherry and CaBP8-mCherry, Figure 1A & B)
localised to vesicular structures throughout the cytosol which
appeared to cluster in a peri-nuclear zone including the TGN [15].
Importantly for this study N-terminally tagged variants of the same
proteins (EYFP-CaBP7 and EYFP-CaBP8, Figure 1A & B) co-
localised extensively with their C-terminally tagged counterparts
(Figure 1A & B overlay) indicating that membrane association was
unaffected by the position of the fluorescent protein tag. We
extended our basic characterisation of the constructs employed in
this study by examining the localisations of co-expressed CaBP7
and CaBP8 in HeLa cells (Figure 1C & D). From these analyses we
concluded that both CaBP7 and CaBP8 co-localised extensively
on the same vesicular structures and that the nature of the
fluorescent protein tag did not interfere with normal targeting of
either protein (Figure 1C & D). We were also able to validate the
correct targeting of fluorescently tagged CaBP8 in HeLa cells by
examination of co-localisation with endogenous CaBP7
(Figure 1E). HeLa cells express CaBP7 endogenously as deter-
mined by immunofluorescence staining with a CaBP7 specific
antibody (Figure 1E, Anti-CaBP7 and western blotting of HeLa
cell lysate with the same antibody, data not shown). The observed
immunostaining pattern for endogenous CaBP7 matched that
observed with tagged exogenous CaBP7 and CaBP8 and displayed
localisation to numerous cytosolic puncta with a concentration of
vesicular structures in a peri-nuclear region. Importantly, in HeLa
cells over-expressing mCherry-tagged CaBP8 (Figure 1E), the
tagged protein displayed extensive colocalisation with endogenous
CaBP7. Collectively these data show that fluorescent protein
tagging of CaBP7 or CaBP8 either N- or C-terminally with
mCherry or EYFP has no impact on normal protein localisation as
assessed by comparison and colocalisation with endogenous
CaBP7.
Trypsin protection analysis of tagged CaBP7 and CaBP8
CaBP7 and CaBP8, at the primary sequence level, have
architectures similar to documented TA proteins. The likely
topology for CaBP7 and CaBP8 at organelle membranes would
therefore correspond to a cytosolically oriented N-terminus,
membrane spanning TM domain and short luminal C-terminus
(Figure 2Ai). This topology, although predicted, required formal
confirmation as alternative arrangements including: 1) N- and C-
termini facing the cytosol with the TM helix only partially
inserting into the membrane (Figure 2Aii) or 2) N-terminus
luminal with C-terminus cytosolic (Figure 2Aiii) were also valid
possibilities. Distinguishing between these topologies represented
an important task as it would firstly indicate if CaBP7 and CaBP8
shared TA class protein organisation and secondly it would
provide a topological basis for published functional effects of
CaBP7 and CaBP8 in the regulation of a cytosolic Golgi
associated enzyme, phosphatidylinositol 4-kinaseIIIb (PI4K,
[22]). In these assays we employed an imaging based protocol
whereby HeLa cells were triply transfected with ECFP protein
and CaBP7 or CaBP8 tagged individually at the N-terminus with
EYFP and at the C-terminus with mCherry. This approach was
based on a well characterised method which had previously been
employed to study the topology of membrane proteins resident on
various cellular organelles including the Golgi apparatus [20].
Digitonin was applied to cells and plasma membrane permeabi-
lisation monitored by loss of soluble cytosolic ECFP. Perfusion
media was then switched to one containing trypsin which now
had cytosolic access and mCherry and EYFP fluorescence signals
at the TGN monitored over time. From Figure 2A it can be
reasoned that if the topology matched that depicted in (i) then an
N-terminal fluorescent tag signal should be eliminated on trypsin
application with a C-terminal tag afforded protection inside the
lumen of the TGN. If the topology were that depicted in
Figure 2A(ii) then both N- and C-terminal fluorescent tag signals
would disappear on trypsin treatment. Finally, if the protein
topology were that depicted in Figure 2A(iii) then only the C-
terminal fluorescent tag signal would be sensitive to the presence
of trypsin. Control experiments were first established whereby
cells were perfused with KHM buffer until a steady fluorescence
baseline had been achieved (Figure 2B(i), CaBP7 and
Figure 2B(v), CaBP8). Digitonin was applied but cells were not
subsequently challenged with trypsin (Figure 2B(iii), CaBP7 and
Figure 2B(vii), CaBP8). The plasma membrane had been
effectively compromised in these cells as determined by loss of
ECFP signal on digitonin treatment (ECFP, Figure 2B (i & iii,
CaBP7) and Figure 2B (v & vii, CaBP8)) however in the absence
of trypsin, as expected, no significant loss of mCherry or EYFP
fluorescence was observed at the TGN in these cells (Figure 2B
and representative fluorescence intensity traces Figure 3A
(CaBP7) and Figure 3C (CaBP8)).
In cells treated with digitonin and then challenged with
trypsin there was a time dependent loss of EYFP signal in both
CaBP7 and CaBP8 expressing cells (Figure 2B(ii), CaBP7 pre-
digitonin/trypsin versus Figure 2B(iv), CaBP7 post-digitonin/
trypsin and Figure 2B(vi), CaBP8 pre-digitonin/trypsin versus
Figure 2B(viii), CaBP8 post-digitonin/trypsin). In contrast
mCherry tagged CaBP7 and CaBP8a tt h eT G Nw e r ep r o t e c t e d
from proteolysis (Figure 2B and representative fluorescence
intensity traces Figure 3B (CaBP7) and Figure 3D (CaBP8)).
Results obtained from multiple independent experiments were
averaged (Figure 3E-H) and clearly demonstrated specific
protection of the mCherry fluorescent tag in the presence of
trypsin (Figure 3F (CaBP7) and Figure 3H (CaBP8)). Since
EYFP was attached to the N-terminus of CaBP7 or CaBP8
whereas mCherry was attached at the C-terminus of both
proteins these data are fully consistent with an N-terminal
cytosolic/C-terminal lumenal topology (Figure 2Ai).
In related experiments, HeLa cells were transfected with
CaBP7 tagged at either the N- or C-terminus with mCherry and
processed in the same manner as described above. In these
analyses cellular protein was instead monitored by western
blotting with mCherry specific antibody (Figure 4). In control
cells expressing mCherry alone and having no exposure to trypsin
a clear immunoreactive band at ,26 kDa is observed which
CaBP7 and CaBP8 Membrane Topology
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17853Figure 1. Localisation of fluorescently tagged CaBP7 and CaBP8 in HeLa cells. A - Exogenously expressed C-terminally tagged CaBP7-
mCherry (red) and N-terminally tagged EYFP-CaBP7 (green). Regions of co-localisation appear yellow in the overlay image. B - Exogenously expressed
C-terminally tagged CaBP8-mCherry (red) and N-terminally tagged EYFP-CaBP8 (green). Regions of co-localisation appear yellow in the overlay image.
C and D - Exogenously co-expressed N-terminally EYFP (green) or mCherry (red) tagged CaBP7 and CaBP8. Co-localisation appears as yellow in overlay
images. E - Exogenously expressed N-terminally tagged mCherry-CaBP8 (red) and immunostained endogenous CaBP7 (Anti-CaBP7, green) in HeLa
cells. Co-localisation appears yellow in the overlay image. Scale bars =10 mm.
doi:10.1371/journal.pone.0017853.g001
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PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e17853Figure 2. Possible CaBP7 and CaBP8 topologies and representative fluorescence protease protection assay images. A – Potential
membrane topologies for CaBP7 and CaBP8 across biological membranes: (i) Type II membrane protein orientation; (ii) Peripheral membrane protein
orientation; (iii) Type I membrane protein orientation. Protein domains are: Green – N-terminal domain; Yellow – Transmembrane domain and Purple
– C-terminal domain. The lipid bilayer is shown in blue. B – HeLa cells transfected with ECFP (blue) and N- and C-terminally tagged: CaBP7-mCherry
CaBP7 and CaBP8 Membrane Topology
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cells expressing N-terminally tagged CaBP7 which were digitonin
permeabilised but not trypsin treated an immunoreactive band at
,50 kDa was observed corresponding to the fusion protein
(Figure 4, mCherry-CaBP7 (2) asterisk). Consistent with our
imaging studies when these cells were challenged with trypsin all
mCherry immunoreactivity was lost (Figure 4, mCherry-CaBP7
(+)) which would be expected if the N-terminal domain of CaBP7
was oriented toward the cytosol. In cells transfected with the C-
terminally tagged variant of CaBP7 (CaBP7-mCherry) the full-
length fusion protein observed in non-trypsinised cells (Figure 4,
CaBP7-mCherry (2) asterisk) was only partially degraded to a
major species migrating at ,30 kDa on SDS-PAGE (Figure 4,
CaBP7-mCherry (+) arrow). Using densitometry quantitation we
were able to determine that the protein remaining in trypsin
treated mCherry-CaBP7 samples was only 25611.9% (n=3
independent experiments, 6 SEM) of that present in trypsin
treated CaBP7-mCherry samples. These results are consistent
with trypsin proteolysis of the CaBP7 N-terminus while the TM
domain, C-terminus and C-terminal mCherry tag remain
protected due to their presence either within the TGN membrane
or lumen.
Since the fusion of peptide tags .25 residues C-terminal to a
TM domain has been shown to cause aberrant processing of the
resultant chimera as a type-II membrane protein [17,26,27] we
have extended our analyses to confirm that CaBP7 and CaBP8
can indeed behave in the same manner as true TA class proteins
through epitope accessibility analysis of a c-myc tag inserted in
the C-terminal tail of the proteins [21] (mCh-CaBP7-myc and
mCh-CaBP8-myc, Figure 5). Unlike the C-terminally mCherry
tagged proteins which have the potential to be processed as
type-II membrane proteins, the C-terminal tail lengths of
mCherry-CaBP7-myc and mCh-CaBP8-myc (20 residues) are
within the aforementioned experimentally determined limit
required for processing as TA proteins. Data derived from these
constructs were consistent with our trypsinisation assays and
showed that following plasma membrane digitonin permeabili-
sation and subsequent fixation mCherry fluorescence was
present but that no anti-myc immunofluorescence was detect-
able (Figure 5A, mCh-CaBP7-myc and Figure 5E, mCh-CaBP8-
myc). In cells fixed and permeabilised with Triton-X-100 prior
to processing for anti-myc immunofluorescence, both mCherry
signal and anti-myc immunoreactivity were detectable
(Figure 5C, mCh-CaBP7-myc and Figure 5G, mCh-CaBP8-
myc). We were additionally able to show that in identically
processed cells the mCherry tag was indeed cytosolic through
immunostaining with an anti-RFP antibody. Anti-RFP immu-
noreactivity was detectable in digitonin (Figure 5B, mCh-
CaBP7-myc and Figure 5F, mCh-CaBP8-myc) permeabilised
cells (in contrast with complete absence of anti-myc immuno-
reactivity in identically treated cells) confirming the cytosolic
orientation of the mCherry tag. Anti-RFP immunoreactivity was
unaffected by Triton-X-100 permeabilisation (Figure 5D, mCh-
C a B P 7 - m y ca n dF i g u r e5 H ,m C h - C aBP8-myc). Collectively,
these data indicate that the C-terminal myc-tags were resident
within an internal sub-cellular membrane compartment that
was only accessible to anti-myc antibody following Triton
permeabilisation of internal membranes.
Discussion
Signalling pathways controlled by fluctuations in intracellular
free Ca
2+ are central to normal mammalian physiology. The
ability of Ca
2+ to regulate a multitude of cellular activities is
fundamentally linked to the expansion and diversification of
dedicated Ca
2+-sensing protein families throughout evolution
[2,3,28]. Specific spatio-temporal Ca
2+ signals are detected and
integrated by proteins having characteristic sub-cellular localisa-
tions, affinities for Ca
2+-binding and restricted sets of target
interactions. The outcome of a given Ca
2+ signal therefore
depends upon the precise nature of the signal (magnitude, timing,
location, oscillatory behaviour etc.) and the biophysical properties
of available Ca
2+-sensor proteins. Precisely how Ca
2+-sensors
target to unique sub-cellular locations is therefore key to our
understanding of how Ca
2+ signals are able to influence exclusive
target interactions and subsequent changes in cellular activity.
Restricting a Ca
2+-sensor to a particular sub-domain within the
cell conceivably allows for target interactions to be influenced over
short time scales and in response to tightly localised Ca
2+-signals.
In contrast Ca
2+-sensors with a higher degree of cellular mobility
might couple to broader spatio-temporal Ca
2+-signals and
generate comparatively slower cellular responses [29].
Post-translational N-myristoylation as a membrane targeting
mechanism in the CaM super-family is well documented and a
multitude of evolutionary adaptations centred on this modifica-
tion have proven functional consequences [8]. CaBP7 and
CaBP8 were initially identified based on homology with CaM [5]
and in common with CaM contained no consensus motifs for
myristoylation. It was somewhat surprising therefore that
expression of both of these proteins in cells led to a distinctive
pattern of localisation to the TGN and vesicles [15]. We clarified
this issue by identifying and characterising a predicted C-
terminal membrane helix that mediated the restricted sub-
cellular localisations of CaBP7 and CaBP8. Outstanding issues
relating to this targeting mechanism concerned firstly whether
the putative hydrophobic C-terminal region was indeed a
functional TM domain? and secondly, what was the exact
topology adopted by both proteins at their target membranes?
The C-terminal position of the CaBP7 and CaBP8 TM helix
strongly resembles the organisation expected of a classic tail-
anchored (TA) protein [18]. This family of proteins typically
have a comparatively large cytosol-oriented N-terminal func-
tional domain a single TM spanning domain and short (typically
,25 residues) C-terminal luminal domain. TA proteins can
therefore be considered a special class of type-II membrane
protein and depending on the exact composition of their TM
domain are directed either to the endoplasmic reticulum (ER)
from where they can traffic on to other destinations along the
secretory pathway or are immediately inserted into the
mitochondrial outer membrane which represents a trafficking
endpoint. In co-localisation studies with mitochondrial markers
we have ascertained that CaBP7 and CaBP8 do not traffic to
these organelles (unpublished data). TA class proteins represent
2.02% of all coding open reading frames in the human genome
[30] and have been implicated in important aspects of cell
physiology ranging from control of mitochondrial function,
apoptosis and intracellular vesicular trafficking. TA proteins lack
(red) + EYFP-CaBP7 (green) or CaBP8-mCherry (red) + EYFP-CaBP8 (green). ‘Pre’ denotes before digitonin application; ‘Post’ denotes following
digitonin and 6 trypsin treatment. Controls before (i and v) and after (iii and vii) digitonin but without trypsin treatment for CaBP7 and CaBP8
respectively. Experiments prior to digitonin application (ii and vi) and following both digitonin and trypsin treatment (iv and viii) for CaBP7 and CaBP8
respectively. Scale bars =10 mm.
doi:10.1371/journal.pone.0017853.g002
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ribosome near translation termination they are not, in the
majority of cases, believed to be co-translationally translocated
across the ER membrane in a Sec61 translocon dependent
fashion [19]. Various studies have examined the requirement for
other protein factors in mediating post-translational insertion of
TA proteins into the ER/mitochondrial membranes and at
present it appears that at least three distinct pathways are
involved in this process, each broadly exhibiting a preference for
TM helices of distinct hydrophobicity [19].
We had previously shown that CaBP7 and CaBP8 are
membrane associated [15]. In this study we have focused on
determining firstly the exact orientation adopted by CaBP7 and
CaBP8 at cellular membranes and secondly whether they are
processed as TA class proteins. These findings are fundamental as
the topologies of CaBP7 and CaBP8 have clear implications for
their reported biological activity in the regulation of the essential
Golgi trafficking enzyme PI4K which is a cytosolic effector [22].
In order for CaBP7 and CaBP8 to interact with PI4K and
respond to fluxes in cytosolic Ca
2+ their EF-hand containing N-
terminal domains, as described, would need to face the cytosol.
Their C-termini could be either luminal (if the TM domain
passed completely across the lipid bilayer) or cytosolic (if the TM
domain only partially integrated into the membrane). It would
however be problematic to reconcile published functional data for
both proteins if their N-terminal domains were oriented toward
the lumen of the TGN. We aimed to distinguish between the
various possible topologies through application of a trypsin
protection analysis [20] of CaBP7 and CaBP8 tagged with
fluorescent protein variants either N- or C-terminally. We
demonstrated that only C-terminal tags are afforded protection
from cytosolic proteolysis. These data indicate that the C-
terminus of both CaBP7 and CaBP8 must reside within the TGN
lumen (their TM helix fully inserts across the lipid bilayer) and
that they do adopt a cytosolic N-terminal topology required for
reported regulation of PI4K. A potential artefact of this assay
relates to the fact that TA proteins are a special instance of type-
II membrane proteins and it has been documented that
appendage of protein tags at the C-terminus of TA-proteins
can result in co-translational processing as typical type-II proteins
[26,27]. In the case of the TA protein cytochrome b5 it has been
demonstrated that addition of up to 85 residues C-terminal to its
TM helix still supports post-translational membrane insertion
[31]. Collectively these studies indicate that there may be
additional determinants within TA protein sequences that are
involved in selection for processing by post-translational mech-
anisms. To further characterise CaBP7 and CaBP8 membrane
insertion we extended our topological analyses to examine
accessibility of a ten residue c-myc epitope inserted within the
C-terminal tail [21]. This inclusion increased the C-terminal
domain length of CaBP7 and CaBP8 to 20 amino acids and
therefore they would still be expected to be processed only by
dedicated TA protein membrane insertion mechanisms. Our data
clearly indicate that the C-terminus of both reporter proteins
reside within the lumen of sub-cellular organelles confirming the
type-II topology suggested by our trypsin protection assays. That
minimal perturbation to the length of the C-terminal tail of
CaBP7 and CaBP8 permits a type-II membrane topology
suggests post-translational processing by a tail-anchor specific
mechanism.
In this study we establish the existence of functional TM
domains in CaBP7 and CaBP8 and describe the first example of
TA protein targeting in the CaM related super-family of small EF-
hand Ca
2+-sensors. TA proteins are conserved throughout
evolution [30] and may represent one of the most primitive
membrane protein architectures. Proteins of this class may have
evolved prior to functional translocon machineries which would be
consistent with their ability to insert into membranes indepen-
dently of this pathway. Interestingly, the CaBP protein sub-family
seems to have appeared at a point in evolution that coincided with
the development of vertebrate species [28] an observation that
renders the use of TA protein targeting in this family all the more
unique. The likely post-translational targeting machinery utilised
by CaBP7 and CaBP8 remains to be determined. Based on
calculated hydrophobicity scores for the CaBP7 and CaBP8 TM
domains of 50.7 and 48.1 respectively [32,33] it might be
speculated that either an Asna-1 [34] or signal-recognition particle
[35] mediated pathway is involved.
Within the CaBP family, CaBP1, CaBP7 and CaBP8 have all
been shown to target in part to the Golgi apparatus where they
perform distinct functions [9,15,22]. In the case of CaBP1,
targeting relies on N-terminal myristoylation [9] whilst CaBP7 and
CaBP8 utilise a C-terminal TM domain that we partially
characterised in previous studies [15] and which we formally
establish in this report. One question that arises is why are distinct
membrane targeting mechanisms required for related Ca
2+-
sensing proteins to associate with the same organelle? Differences
Figure 3. Example fitted curves from individual fluorescence protease protection assays. A and C - Control experiments without trypsin
treatment for CaBP7 and CaBP8 respectively. B and D - CaBP7 and CaBP8 treated with both digitonin and trypsin. Solid lines represent C-terminally
mCherry tagged CaBP7 or CaBP8, dashed lines represent N-terminally EYFP tagged CaBP7 or CaBP8 and dotted lines represent ECFP fluorescence.
Frame rate =1 frame/8 sec. Histograms for averaged fluorescence protease protection assay results. E and G - Control experiments without trypsin
treatment for CaBP7 and CaBP8 respectively. F and H - CaBP7 and CaBP8 treated with both digitonin and trypsin. Key: Black = before treatment with
digitonin, Grey = after treatment with digitonin, White (Controls E and G) = End of experiment with no trypsin treatment, White (F and H) = End of
experiment post-trypsin treatment. (E) n=7 cells, (F) n=12 cells, (G) n=7 cells, (H) n=7 cells. Data are plotted as mean 6 SEM.
doi:10.1371/journal.pone.0017853.g003
Figure 4. Biochemical protease protection assay. HeLa cells
expressing mCherry control protein, mCherry-CaBP7 or CaBP7-mCherry
were digitonin permabilised followed by incubation 6 trypsin. Cells
were lysed, protein resolved on SDS-PAGE and mCherry detected by
immunoblotting with polyclonal anti-RFP antibody. (*) - Denotes full
length mCherry-CaBP7 or CaBP7-mCherry; (r) - Denotes the major
proteolytic fragment generated from CaBP7-mCherry following trypsin
digestion. Molecular weight standards (kDa) are shown on the left side
of the image.
doi:10.1371/journal.pone.0017853.g004
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CaBP7/CaBP8 could be solely due to the existence of specific
target-protein interactions mediated by the CaBPs themselves.
This interpretation fails to explain our observations regarding
diversification in membrane targeting (myristoylation versus TM
domain) and it is tempting to speculate that this has a similarly
important role to play in protein function perhaps through spatial
restriction to membrane micro-domains on the same organelle
which could conceivably influence target protein interaction
specificity.
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